Head to head for first-timers
CoreAge Rx vs Invyncible
CoreAge Rx and Invyncible both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxInvyncible
Rank #117 for first-timers · Grade C
Mama-Match
Best for: A mom who wants the option to start compounded and later move to a brand-name pen without switching providers.
Visit InvyncibleThe verdict for a first step
CoreAge Rx edges out Invyncible on the Mama-Match Score, 94 to 47 (A vs C). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Invyncible is still a genuine option — invyncible offers a first-time mom either cheaper compounded semaglutide ($192.50/mo against a $275.00 reference price) or tirzepatide ($210/mo against $300.00), or an FDA-approved Wegovy ($1,750/mo) or Zepbound ($1,540/mo) pen, on the same account — genuinely useful if your needs change — but it won't confirm your state's availability until you're already in the intake, and it discloses its corporate parent and street address rather than hiding behind a trade name, with a LegitScript seal displayed alongside them. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | Invyncible |
|---|---|---|
| Mama-Match Score | 94/100 · A | 47/100 · C |
| Overall rank | #1 | #117 |
| Semaglutide | $99/mo | $192.50/mo |
| Tirzepatide | $149/mo | $210/mo |
| Coverage | All 50 states | Not publicly disclosed; confirmed during intake |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
Invyncible
Rank #117 · Grade C
What we like
- Discloses its corporate parent and a physical address instead of hiding behind a brand name
- LegitScript-verified
- Both compounded programs and FDA-approved Wegovy/Zepbound on the same account
The caveats
- No state-availability list — confirmed only during intake
- Every price is shown as a permanent 'sale' against a higher reference figure that never seems to actually apply
- Brand-name pricing ($1,540–$1,750/mo) still runs well above most insurance-covered options
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Invyncible with the other providers we review for women.
Or browse the full comparison hub.